Independent fund research. Built on SEC filings.

How we research funds

ETF · Small-Cap · Invesco

Invesco S&P SmallCap 600 Pure Growth ETF (RZG)

Ticker RZG · Index fund · Since 2006-03-01 · · Holdings as of Jul 31, 2026

Expense ratio
0.35%$35/yr per $10k
5-yr return
+4.4%annualized
1-yr return
+10.2%as of Dec 2025
Net assets
$137.8Mall share classes
Holdings
131

Bottom line

Is RZG a good fund? The bottom line

RZG is an index small-cap ETF from Invesco.

Annual fees run 0.35% — about $35 a year on every $10,000 invested, cheaper than 92% of small-cap funds we track.

It returned +10.2% over one year, +4.4% a year over five years, +8.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $138 million in net assets and 131 holdings, its largest position is Invesco Private Prime Fund (21.5%) and the top 10 make up 44% of the portfolio.

What stands out

  • Low cost: cheaper than 92% of small-cap peers

What to watch

  • 5-year return in the bottom quarter of its category

Updated Nov 19, 2026

What RZG invests in

The Invesco S&P SmallCap 600 Pure Growth ETF (the Fund) seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600 Pure Growth Index (the Underlying Index).

The Fund is an index fund that seeks to track the investment results of the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (S&P DJI or the Index Provider) compiles, maintains and calculates the Underlying Index, which is composed of a subset of securities from the S&P SmallCap 600 Index (the Parent Index) that exhibit strong growth characteristics. First, each security in the Parent Index is assigned two style scores one for growth and one for valuebased on the characteristics of the issuer. The growth score is measured using three factors: three-year sales per share growth rate, the ratio of the three-year net change in earnings per share to current price per share, and momentum (the 12-month percentage change in price). The value score is measured using three other factors: book-value-to-price ratio, earnings-to-price…

From the fund's prospectus (filed Aug 27, 2026).

RZG performance

Fund calendar-year total returns, 2015–2025 2015: +0.9%; 2016: +20.6%; 2017: +17.9%; 2018: −7.7%; 2019: +14.3%; 2020: +17.6%; 2021: +21.0%; 2022: −29.0%; 2023: +19.1%; 2024: +9.8%; 2025: +10.2% +1% 2015 +21% 2016 +18% 2017 −8% 2018 +14% 2019 +18% 2020 +21% 2021 −29% 2022 +19% 2023 +10% 2024 +10% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
RZG+10.2%+4.4%+8.1%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full RZG performance history →

What RZG costs

On a $10,000 investment, RZG's 0.35% expense ratio costs about $35 a year. The prospectus estimates $444 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full RZG fee table →

RZG top 10 holdings

#Holding% of fund
1Invesco Private Prime Fund21.55%
2Invesco Private Government Fund8.30%
3ACM Research, Inc.2.36%
4Dave Inc.1.87%
5Protagonist Therapeutics, Inc.1.78%
6Acadian Asset Management Inc.1.68%
7Chefs' Warehouse, Inc. (The)1.64%
8StoneX Group Inc.1.62%
9Liquidia Corp.1.60%
10Enova International, Inc.1.57%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 44% of the fund. See all top 25 holdings and asset mix →

Alternatives to RZG

More funds like RZG →

RZG FAQ

What is the expense ratio of RZG?
RZG's expense ratio is 0.35%, which works out to about $35 a year for every $10,000 invested. The prospectus estimates total costs of $444 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RZG a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 92% of small-cap peers; 5-year return in the bottom quarter of its category. This is general information, not personalized advice.
What does RZG hold?
RZG's largest holdings are Invesco Private Prime Fund (21.5%), Invesco Private Government Fund (8.3%), ACM Research, Inc. (2.4%), Dave Inc. (1.9%), Protagonist Therapeutics, Inc. (1.8%). It holds 131 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is RZG's 5-year return?
RZG returned +4.4% a year over the five years ending Dec 31, 2025, and +8.1% a year over ten years. Past performance does not guarantee future results.
Who manages RZG?
RZG is offered by Invesco through Invesco Exchange-traded Fund Trust.